Diabetes Nutrition Market Opportunities & Forecast 2025-2032

Diabetes Nutrition Market is estimated to be valued at USD 6,486.7 Mn in 2025 and is expected to reach USD 10,080.2 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032. Diabetes nutrition include proteins, amino acids, omega-3 fatty acids, alpha-lipoic acid, herbal supplements, soluble fiber, probiotics, carbohydrates, and antioxidants. Diabetes nutrition helps the body to lower the blood glucose level, as extra calories and fats creates the undesirable rise in blood glucose level.

Figure 1. Global Diabetes Nutrition Market Share (%), by Form, 2025

Diabetes Nutrition Market Share by Form

To learn more about this report, Request sample copy

Global Diabetes Nutrition Market - Driver

Increasing strategies adopted by key market players, such as product launches, is expected to drive the global diabetes nutrition market over the forecast period. For instance, in June 2020, Pendulum, a biotechnology company, announced that they had launched pendulum glucose control, the first medical probiotic for the dietary management of type 2 diabetes. Pendulum glucose control targets the gut microbiome to manage blood sugar level.

Diabetes Nutrition Market Report Coverage

Report Coverage	Details
Base Year:	2024	Market Size in 2025:	USD 6,486.7 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.5%	2032 Value Projection:	USD 10,080.2 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Standard Nutrition (Balanced macronutrient formulations), Disease-Specific Nutrition (Specialized for diabetes management) By Mode of Administration: Enteral Nutrition, Parenteral Nutrition, Oral Nutrition, By Nutritional Components: Proteins, Carbohydrates, Fats, Vitamins & Minerals, Amino Acids, Fiber, Others (Electrolytes, Probiotics, Phytochemicals) By Form: Powder, Liquid, Tablets, Soft Gels, Others (Nutritional Gummies, Bars, etc.) By Patient Type: Pediatric, Adult, Geriatric, By Indication: Prediabetic and Metabolic Syndrome, Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Juvenile Diabetes By Category of Prescription: Prescription, Over-the-Counter (OTC), By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, E-commerce, Others (Hypermarkets, Convenience Stores, among others), By End User: Hospitals, Ambulatory Surgical Centers, Long Term Care Facilities, Others (Clinics, Research centers, among others)
Companies covered:	Abbott., Reckitt Benckiser Group PLC., Hexagonnutrition Ltd., Nestlé, Danone, Baxter, Fresenius Kabi AG, B. Braun SE, Furious Nutritions, Nature's One, Otsuka Pharmaceutical Factory, Inc., Scientific Brain Nutraceutical Pvt. Ltd., Centrum (GSK plc.), BASF SE, DSM, Zeon Lifesciences Ltd., Zenova Bio Nutrition, Nuflower Foods & Nutrition Pvt. Ltd., KD Chem Pharma, Pentasure Nutrition, Akums Drugs and Pharmaceuticals Ltd., Bionova, Zoic Pharmaceuticals., Fermentis Life Sciences, Other Prominent Players,
Growth Drivers:	Adoption of inorganic strategies such as product launches by key market players
Restraints & Challenges:	Increasing number of product recalls by regulatory authorities such as U.S. Food and Drug Administration

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Figure 2. Global Diabetes Nutrition Market Share (US$ Million), by Region, 2025

Diabetes Nutrition Market Share by Region

To learn more about this report, Request sample copy

Global Diabetes Nutrition Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

The COVID-19 pandemic also had a positive impact on the global diabetes nutrition market growth during COVID-19. For instance, according to the data published in Springer Journal, in April 2021, as nutrition plays an important role in immunity, adequate intake of dietary protein, fiber, essential fatty acids and some micronutrients especially vitamins D, C, B12, folate, zinc and selenium has beneficial effects on the prevention and treatment of COVID-19 in diabetic patients through modulation of innate and adaptive immune responses or direct effects on virus enzymes or the rate of cell entrance.

Global Diabetes Nutrition Market: Key Developments

The adoption of inorganic growth strategies such as product launches by key market players is expected to drive the global diabetes nutrition market growth. For instance, in December 2021, Danone India, a manufacturer of nutrion products, announced that they had launched Protinex Diabetes Care to address the nutritional requirements of Indians with diabetes. The product aims to provide adequate protein and fiber, which are important nutrients in managing blood sugar levels.

Global Diabetes Nutrition Market: Restraint

Increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration is expected to hinder the market growth. For instance, in November 2020, the U.S. Food and Drug Administration recalled metformin hydrochrolide,a medication for glucose management in patients with type 2 diabetes which was manufactured by Marksans Pharma, a pharmaceutical company. The drug was recalled due the detection of of high levels of N-nitrosodimethylamine, an organic compound linked to causing cancer in high concentrations.

Global Diabetes Nutrition Market - Key Players

Major players operating in the global diabetes nutrition market include Abbott., Reckitt Benckiser Group PLC., Hexagonnutrition Ltd., Nestlé, Danone, Baxter, Fresenius Kabi AG, B. Braun SE, Furious Nutritions, Nature's One, Otsuka Pharmaceutical Factory, Inc., Scientific Brain Nutraceutical Pvt. Ltd., Centrum (GSK plc.), BASF SE, DSM, Zeon Lifesciences Ltd., Zenova Bio Nutrition, Nuflower Foods & Nutrition Pvt. Ltd., KD Chem Pharma, Pentasure Nutrition, Akums Drugs and Pharmaceuticals Ltd., Bionova, Zoic Pharmaceuticals., Fermentis Life Sciences, Other Prominent Players,

About Author

Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.

Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.

Missing comfort of reading report in your local language? Find your preferred language :

Transform your Strategy with Exclusive Trending Reports :

Codeine Market

Tacrolimus Market

Polyether Antibiotics Market

Cathepsin Inhibitors Market

Bacteriostatic Antibiotics Market

Narcotics Analgesics Market

Frequently Asked Questions

The Diabetes Nutrition Market is estimated to be valued at USD 6,486.7 Mn in 2025, and is expected to reach USD 10,080.2 Mn by 2032.

The CAGR of the Diabetes Nutrition Market is projected to be 6.5% from 2025 to 2032.

Increasing strategies adopted by key market players such as product launches is expected to drive the market.

Tablets is the leading form segment in the market.

The key factors hampering the market include the increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration.

Major players operating in the market include Abbott., Reckitt Benckiser Group PLC., Hexagonnutrition Ltd., Nestlé, Danone, Baxter, Fresenius Kabi AG, B. Braun SE, Furious Nutritions, Nature's One, Otsuka Pharmaceutical Factory, Inc., Scientific Brain Nutraceutical Pvt. Ltd., Centrum (GSK plc.), BASF SE, DSM, Zeon Lifesciences Ltd., Zenova Bio Nutrition, Nuflower Foods & Nutrition Pvt. Ltd., KD Chem Pharma, Pentasure Nutrition, Akums Drugs and Pharmaceuticals Ltd., Bionova, Zoic Pharmaceuticals., Fermentis Life Sciences, Other Prominent Players